Adamas Pharmaceuticals Selects Veeva CRM to Support New Product Commercialization and Anticipated Growth.

PLEASANTON, Calif. -- Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System's VBioPharma[TM] KOL Edition - part of the Veeva CRM suite. Selection of Veeva's SaaS solution marks an important step in Adamas' early-stage product commercialization strategy. Veeva CRM is currently being rolled out to Adamas' customer facing teams in sales and marketing and clinical management, and will scale with the company as it grows.

Adamas initially considered making the heavy investment in a custom-built system that would support the company's unique needs until being recommended to Veeva CRM for its specialized KOL functionality, low cost, and ease of customization. Veeva demonstrated the productOand Adamas was immediately convinced. Executives cited the product's flexibility - both in terms of licensing and system configuration; its scalability; and, its world-class performance from economies of scale only possible with multi-tenant SaaS applications.

"We researched the market and even considered a home-grown alternative, but no other system delivered the specific KOL functionality that we needed plus the outstanding flexibility and scalability of a large-scale enterprise system," said Michael Cheung, director of information technology at Adamas. "In fact, the product has proven so deeply flexible that we have been able to customize it for our clinical trial management team as well. One system with a huge data repository and multiple tools for all of our needs and everyone to useOthis is the way all companies should operate."

According to Veeva's Executive Vice President and General Manager, Matt Wallach, "We're proud to be a part of Adamas' exciting entry into the industry because we have the right infrastructure to help this company launch its product and expand quickly. Our multi-tenant SaaS architecture truly levels the playing field for emerging life sciences leaders like Adamas because they benefit from the advantages of world-class technology they might not otherwise be able to afford."

About Veeva CRM

The Veeva CRM suite of applications, comprised of VBioPharma[TM], VMobile[TM], and VInsights[TM], is the life sciences industry's top multi-tenant SaaS-based CRM solution. As the foundation, VBioPharma offers multiple editions in one CRM product to accommodate the unique needs of various life sciences commercial teams. It is also the only Pharma CRM application to come pre-validated for PDMA and 21 CFR Part 11 compliance. The complete Veeva CRM suite gives customers the mobility and reporting solutions needed to drive user adoption and sales effectiveness.

About Veeva Systems

Veeva Systems is the leader in multi-tenant SaaS-based solutions for the global life sciences industry. Veeva has dozens of customers ranging from the world's largest pharmaceutical companies with thousands of users to emerging biotechs commercializing their first products. Veeva customers achieve the fastest time to value through the deployment of fully functional applications that are flexible, simple to deploy, inexpensive to operate, and provide a superior user experience. Veeva is a privately-held company headquartered in Pleasanton, CA. For more information, visit www.veevasystems.com.